Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.

Pradhan R, Kim YI, Chang SW, Kim JO.

Int J Pharm. 2014 Jan 2;460(1-2):205-11. doi: 10.1016/j.ijpharm.2013.10.040. Epub 2013 Oct 29.

PMID:
24184032
[PubMed - indexed for MEDLINE]
2.

A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.

Cao QR, Choi JS, Liu Y, Xu WJ, Yang M, Lee BJ, Cui JH.

Drug Dev Ind Pharm. 2013 Nov;39(11):1720-30. doi: 10.3109/03639045.2012.730528. Epub 2012 Oct 15.

PMID:
23062115
[PubMed - indexed for MEDLINE]
3.

In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.

Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME.

Drug Dev Ind Pharm. 2013 Nov;39(11):1651-62. doi: 10.3109/03639045.2012.729146. Epub 2012 Oct 24.

PMID:
23094867
[PubMed - indexed for MEDLINE]
4.

Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.

Sun F, Sui C, Teng L, Liu X, Teng L, Meng Q, Li Y.

Int J Pharm. 2010 Sep 15;397(1-2):44-9. doi: 10.1016/j.ijpharm.2010.06.042. Epub 2010 Jun 30.

PMID:
20600717
[PubMed - indexed for MEDLINE]
5.

Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder.

Sun F, Sui C, Zhou Y, Liu X, Shi Y, Wu Y, Li Y.

Int J Pharm. 2013 Sep 15;454(1):532-8. doi: 10.1016/j.ijpharm.2013.07.041. Epub 2013 Jul 23.

PMID:
23891744
[PubMed - indexed for MEDLINE]
6.

Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine.

Olsson B, Szamosi J.

Clin Pharmacokinet. 2001;40(3):227-35.

PMID:
11327200
[PubMed - indexed for MEDLINE]
7.

Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.

Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, Anju P, Prasanna S.

Arch Pharm Res. 2007 Feb;30(2):222-34.

PMID:
17366745
[PubMed - indexed for MEDLINE]
8.

Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.

Prasanthi D, Lakshmi PK.

Int Braz J Urol. 2013 Jan-Feb;39(1):63-75; discussion 76. doi: 10.1590/S1677-5538.IBJU.2013.01.09.

PMID:
23489517
[PubMed - indexed for MEDLINE]
Free Article
9.

Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.

Mutalik S, Manoj K, Reddy MS, Kushtagi P, Usha AN, Anju P, Ranjith AK, Udupa N.

AAPS PharmSciTech. 2008;9(2):651-9. doi: 10.1208/s12249-008-9075-3. Epub 2008 May 24.

PMID:
18500561
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
11.

Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.

Huang Y, Khanvilkar KH, Moore AD, Hilliard-Lott M.

Drug Dev Ind Pharm. 2003 Jan;29(1):79-88.

PMID:
12602495
[PubMed - indexed for MEDLINE]
12.

Effect of antacid on the pharmacokinetics of extended-release formulations of tolterodine and oxybutynin.

Sathyan G, Dmochowski RR, Appell RA, Guo C, Gupta SK.

Clin Pharmacokinet. 2004;43(14):1059-68.

PMID:
15530134
[PubMed - indexed for MEDLINE]
13.

Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.

Dmochowski R, Chen A, Sathyan G, MacDiarmid S, Gidwani S, Gupta S.

J Clin Pharmacol. 2005 Aug;45(8):961-8.

PMID:
16027408
[PubMed - indexed for MEDLINE]
14.

Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components.

Barakat NS, Elbagory IM, Almurshedi AS.

Drug Deliv. 2009 Jan;16(1):57-65. doi: 10.1080/10717540802518157.

PMID:
19555310
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.

Khanvilkar KH, Huang Y, Moore AD.

Drug Dev Ind Pharm. 2002 May;28(5):601-8.

PMID:
12098849
[PubMed - indexed for MEDLINE]
16.

Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.

Sahoo J, Murthy PN, Biswal S, Sahoo SK, Mahapatra AK.

AAPS PharmSciTech. 2008;9(2):577-82. doi: 10.1208/s12249-008-9092-2. Epub 2008 May 6.

PMID:
18459050
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.

Castellanos Gil E, Iraizoz Colarte A, Lara Sampedro JL, Bataille B.

Eur J Pharm Biopharm. 2008 May;69(1):303-11. Epub 2007 Oct 30.

PMID:
18053697
[PubMed - indexed for MEDLINE]
18.

In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product.

Nair A, Gupta R, Vasanti S.

Pharm Dev Technol. 2007;12(6):621-5.

PMID:
18161635
[PubMed - indexed for MEDLINE]
19.

Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.

Sankalia JM, Sankalia MG, Mashru RC.

J Control Release. 2008 Jul 2;129(1):49-58. doi: 10.1016/j.jconrel.2008.03.016. Epub 2008 Mar 26.

PMID:
18456362
[PubMed - indexed for MEDLINE]
20.

Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.

Reddy KR, Mutalik S, Reddy S.

AAPS PharmSciTech. 2003 Dec 12;4(4):E61.

PMID:
15198556
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk